‘Mysterious’ Pneumonia Outbreaks Reported in China
News reports of outbreaks of a bacterial respiratory illness known as mycoplasma pneumoniae pneumonia (MPP) in northern China began to emerge in October 2023. The outbreaks, primarily among children, have been attributed by public health professionals to “declining immunity levels” in people as a result of “preventive measures” taken in over the past three years […]
U.S. Colleges, Companies Reinstate COVID Mask and Vaccine Mandates
Even though the World Health Organization (WHO) and U.S. government declared an end to the COVID-19 public health emergency in May 2023, some colleges and companies in the United States have announced they will be reinstating mandates to force people to wear masks and get COVID shots as a condition of getting a college education […]
Novel mRNA Lyme Shots Could Be Released in 2025
Two novel messenger RNA (mRNA) shots for Lyme disease currently in late-stage clinical trials could hit the market as early as 2025, Moderna announced earlier this year. Also in the race to develop the first-ever mRNA product to prevent Lyme disease are Pfizer and Austria-based Valneva, which entered into a collaborative agreement in April 2020 […]
Natural Immunity Wins Again
A new study in The Lancet has confirmed that natural immunity from COVID infection is at least as protective and durable against severe complications as vaccination. Yet again, another COVID “conspiracy theory” has become today’s “The Science™.” Natural immunity has long been a well known and accepted part of immunology, despite rabid, frenzied attempts to discredit it. Anthony […]
Millions Harmed by Medical Misdiagnosis in U.S. Hospital Emergency Rooms
A new study published by the U.S. Department of Health and Human Services’ Agency for Healthcare Research and Quality (AHRQ) on Dec. 15, 2022 estimates that about six percent of the approximately 130 million people (about one in 18 individuals) who seek medical care in emergency departments (ED) in the United States each year are […]
Safety and Effectiveness of New COVID Bivalent Boosters Based on a Study of Eight Mice?
With no safety and efficacy evidence from human clinical trials, on Aug. 31, 2022, the U.S. Food and Drug Administration (FDA) amended the Emergency Use Authorizations (EUAs) for Pfizer/BioNTech’s Comirnaty and Moderna/NIAID’s Spikevax messenger RNA (mRNA) COVID-19 biologics to distribute “bivalent formulations” (two-in-one) of the shots to use as a “single booster dose.”1 2 The […]
